Introduction

Archivi

Here’s How Missouri Spends Its Legal Marijuana Revenue

This article originally appeared at https://missouriindependent.com/2023/05/31/where-does-the-revenue-from-missouri-marijuana-sales-and-license-fees-go/ Since Missouri’s marijuana sales began in 2019, the state has collected nearly $100 million in revenue from taxes and program fees, according to state authorities.  Etched in the state’s constitution is a road map for where the revenue can go.  The first stop is operational costs. By law, any […]

Estimating the effects of legalizing recreational cannabis on newly incident cannabis use

This originally appeared at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302774/ Authors : Barrett Wallace Montgomery, Conceptualization, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing, 1 ,*Meaghan H. Roberts, Formal analysis, Methodology, Validation, Writing – review & editing, 2 Claire E. Margerison, Methodology, Project administration, Supervision, Writing – review & editing, 1 and James C. […]

Marijuana Is Safer Than Alcohol And Cigarettes—And Is Less Addictive Than Technology—Americans Say In New Survey

This originally appeared at https://www.psychiatry.org/News-room/News-Releases/New-APA-Poll-Finds-Americans-Rate-Cigarettes-as-Mo More People Deem Cigarettes Dangerous, Addictive Than Vaping, Opioids, Technology and Alcohol Washington, D.C. – In a new national poll, Americans widely agreed that cigarettes are unsafe (84%) and addictive (87%), and yet a fifth (21%) reported smoking every day. The vast majority of people believe alcohol, opioids, and vapes […]

Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1

This article originally appeared at https://www.sciencedirect.com/science/article/abs/pii/S0006295214004201 Authors Institute of Toxicology and Pharmacology, University of Rostock, Rostock, GermanybSection of Molecular Oncology and Immunotherapy, Department of General Surgery, University of Rostock, Rostock, GermanycDepartment of Radiotherapy and Radiation Oncology, University of Rostock, Rostock, Germany https://doi.org/10.1016/j.bcp.2014.07.014 Abstract Cannabinoids have been shown to promote the expression of the intercellular adhesion […]

Reduction of Benzodiazepine Use in Patients Prescribed Medical Cannabis

This originally appeared at https://www.liebertpub.com/doi/10.1089/can.2018.0020 Authors Chad Purcell Andrew Davis Nico Moolman, and S. Mark Taylor Published Online:23 Sep 2019 https://doi.org/10.1089/can.2018.0020 Abstract Background: Benzodiazepines are a class of medication with sedative properties, commonly used for anxiety and other neurological conditions. These medications are associated with several well-known adverse effects. This observational study aims to investigate the reduction […]

5% of Irish Doctors Regularly Smoke Cannabis

This article originally appeared at https://www.independent.ie/irish-news/health/anonymous-survey-finds-support-among-irish-doctors-for-use-of-cannabis/a826718194.html The Irish Medical Times survey revealed 37pc of doctors have tried cannabis, while a majority, 54pc, support the decriminalisation of small quantities of the drug for personal use. It also showed 8pc of doctors use cannabis — with 5pc using it “regularly”. The anonymous survey involved 89 Irish doctors […]

UK patient secures first NHS reimbursement for cannabis flowers

This article originally appeared at https://cannabishealthnews.co.uk/2023/06/15/zerenia-clinics-uk-patient-first-to-secure-nhs-reimbursement-for-cannabis-flowers/ A patient of Zerenia Clinics UK has made history as the first to secure NHS reimbursement for prescribed cannabis flowers. After a patient from Zerenia Clinics UK was reimbursed by the NHS for their therapy with cannabis-based oral extracts in January 2023, a second patient from the clinic has […]

Multiple Sclerosis and Use of Medical Cannabis: A Retrospective Review of a Neurology Outpatient Population

This article originally appeared at https://pubmed.ncbi.nlm.nih.gov/37250194/ Authors Michelle M. Rainka, PharmD; Traci S. Aladeen, PharmD; Anna G. Mattle, PharmD, MS; Emily Lewandowski, PharmD; Denis Vanini, PharmD; Katelyn McCormack, NP; Laszlo Mechtler, MD Int J MS Care (2023) 25 (3): 111–117. https://doi.org/10.7224/1537-2073.2022-006 ABSTRACT BACKGROUND Patients diagnosed as having multiple sclerosis (MS) experience a wide range of […]

Cannabidiol as an adjuvant treatment in adults with drug-resistant focal epilepsy

This article originally appeared at https://pubmed.ncbi.nlm.nih.gov/37196452/ Authors Silvia Kochen  1 , Manuela Villanueva  1 , Liliana Bayarres  1 , Anilu Daza-Restrepo  1 , Silvia Gonzalez Martinez  1 , Silvia Oddo  2 Highlights Abstract Cannabidiol oil (CBD) has been approved as an anti-seizure medication for the treatment of uncommon types of epilepsy, occurring in children: Dravet syndrome, Lennox-Gastaut syndrome, and Tuberous […]